Macrophage and chondrocyte phenotypes in inflammation

Abstract

Inflammation is a complex biological process protecting the body from diverse external threats. Effectively performing this task requires an intricate, well-regulated interplay of different cells and tissues. Furthermore, several cells participating in inflammation can assume diverse phenotypes.

A classic and relatively well-studied example of phenotypic diversity in inflammation is macrophage polarization. Based on the T_H1/T_H2 phenotypes of T helper cells, this scheme has proinflammatory “classical/M1” activation contrasted with the anti-inflammatory and healing-promoting “alternative/M2” phenotype. Some authors have extended the concept into an M17 phenotype induced by the classic T_H17 cytokine IL-17. Phenotypic changes in chondrocytes have also been studied especially in the context of osteoarthritis (OA), and there are indications that these cells can also assume polarized phenotypes at least partly analogous to those of T_H cells and macrophages. The therapeutic success of biological agents targeting T_H1/T_H2/T_H17 inductor and/or effector cytokines displays the utility of the concept of polarization. The aim of this focused review is to survey the internal and external factors affecting macrophage and chondrocyte phenotypes (such as inflammatory cytokines, widely used medications and natural products) and to explore the possibility of ameliorating pathological states by modulating these phenotypes.